These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3377908)

  • 21. Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents.
    Jacobs SP; Wodinsky I; Kensler CJ; Venditti JM
    Cancer Chemother Rep; 1970 Oct; 54(5):329-35. PubMed ID: 5514622
    [No Abstract]   [Full Text] [Related]  

  • 22. Suppression of Rauscher virus-induced leukemia by L-asparaginase.
    Campbell WF; Levine AS
    Life Sci; 1969 Oct; 8(20):1033-40. PubMed ID: 5355416
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of l-asparaginase and asparagine deprivation on RNA metabolism in mouse leukemia L 5178Y cells in suspension culture.
    Nakashima T; Kuwano M; Akiyama S; Endo H
    Cancer Res; 1976 Oct; 36(10):3616-21. PubMed ID: 986238
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effective complexes of the antileukemic enzyme L-asparaginase with dextran sulfate].
    Karsakevich AS; Dauvarte AZh; Zvirgzda IK; Lebedeva LV; Vina IA
    Vopr Med Khim; 1986; 32(4):47-51. PubMed ID: 2429444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Asparaginyl-tRNA and resistance of murine leukaemias to L-asparaginase.
    Gallo RC; Longmore JL; Adamson RH
    Nature; 1970 Sep; 227(5263):1134-6. PubMed ID: 5451107
    [No Abstract]   [Full Text] [Related]  

  • 26. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V; Spackman D; Fitzmaurice MA; Roberts J; Holcenberg JS; Dolowy WC
    Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of L-asparaginase preparations of E. coli and agouti serum on the homograft reactivity in the mouse.
    Schulten HK; Giraldo G
    Recent Results Cancer Res; 1970; 33():155-9. PubMed ID: 4949159
    [No Abstract]   [Full Text] [Related]  

  • 28. Optimization of dansyl derivatization and chromatographic conditions in the determination of neuroactive amino acids of biological samples.
    Kang X; Xiao J; Huang X; Gu Z
    Clin Chim Acta; 2006 Apr; 366(1-2):352-6. PubMed ID: 16406032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measurement of serum L-asparagine in the presence of L-asparaginase requires the presence of an L-asparaginase inhibitor.
    Asselin BL; Lorenson MY; Whitin JC; Coppola DJ; Kende AS; Blakley RL; Cohen HJ
    Cancer Res; 1991 Dec; 51(24):6568-73. PubMed ID: 1742729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.
    Boos J; Werber G; Ahlke E; Schulze-Westhoff P; Nowak-Göttl U; Würthwein G; Verspohl EJ; Ritter J; Jürgens H
    Eur J Cancer; 1996 Aug; 32A(9):1544-50. PubMed ID: 8911116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experimental investigations on problems of the clinical use of L-asparaginase.
    Bierling R
    Recent Results Cancer Res; 1970; 33():114-24. PubMed ID: 4115400
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of asparaginase on cell membranes of sensitive and resistant mouse lymphoma cells.
    Ankel EG; Zirneski J; Ring BJ; Holcenberg JS
    In Vitro; 1984 May; 20(5):376-84. PubMed ID: 6724617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of 27 dansyl amino acid derivatives in biological fluids by reversed-phase high-performance liquid chromatography.
    Márquez FJ; Quesada AR; Sánchez-Jiménez F; Núñez de Castro I
    J Chromatogr; 1986 Aug; 380(2):275-83. PubMed ID: 3760057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural and asparaginase induced death of L5178Y leukemia cells in vivo.
    Hofer KG; DiBenedetto J; Hughes WL
    Z Krebsforsch; 1970 Nov; 75(1):34-44. PubMed ID: 4252828
    [No Abstract]   [Full Text] [Related]  

  • 35. [Amino acid concentration in plasma and blood cells during coli-L-asparaginase therapy].
    Höcker P; Stacher A; Weiser M
    Blut; 1972 Jul; 25(1):9-19. PubMed ID: 4505116
    [No Abstract]   [Full Text] [Related]  

  • 36. Glutamate oxidation of 6C3HED lymphoma: effects of L-asparaginase on sensitive and resistant lines.
    Lavietes BB; Regan DH; Demopoulos HB
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):3993-7. PubMed ID: 4530280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-asparaginase--antileukemia agent.
    Bukhari SZ; Yaqub M
    J Pak Med Assoc; 1977 Jan; 27(1):262-4. PubMed ID: 19639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum amino acids in acute leukemia of the adult during asparaginase therapy].
    Tilz GP; Stübchen-Kirchner H
    Blut; 1972 Nov; 25(5):314-7. PubMed ID: 4508723
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of the LDH-elevating virus in leukemia therapy by asparaginase.
    Riley V
    Nature; 1968 Dec; 220(5173):1245-6. PubMed ID: 5725988
    [No Abstract]   [Full Text] [Related]  

  • 40. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
    Schwartz SA; Morgenstern B; Capizzi RL
    Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.